The Institute for the Future’s X2 project is all about tracing future trends in science and technology As the steward of the Biomedical Sciences and Biotechnology Group I collect signals in these fields on which some forecasts can be based later on. Here are some issues I found future sensitive enough recently:
GlaxoSmithKline collaborates with the Harvard Stem Cell Institute
Pfizer’s growing and various interests in stem cells
Regaining vision with gene therapy using adeno-associated viruses Read the rest of this entry »
